GENEVA, Nov. 11 -- VERTEX PHARMACEUTICALS INCORPORATED (50 Nothern AvenueBoston, Massachusetts 02210) filed a patent application (PCT/US2025/026890) for "GENETICALLY ENGINEERED CELLS" on Apr 29, 2025. With publication no. WO/2025/231031, the details related to the patent application was published on Nov 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): COOKE, Michael (c/o Vertex Pharmaceuticals Incorporated50 Northern AvenueBoston, Massachusetts 02210), CONWAY, Michael (c/o Vertex Pharmaceuticals Incorporated50 Northern AvenueBoston, Massachusetts 02210), KISSLER, Stephan (c/o Vertex Pharm...